09/06/2024 3:57 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 4:25 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 10:43 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024 4:24 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
09/04/2024 12:16 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024 3:48 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 3:27 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/03/2024 7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/03/2024 7:02 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/30/2024 3:26 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 3:53 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024 3:49 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/27/2024 3:10 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 3:42 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 4:25 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/22/2024 5:48 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 3:25 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024 6:09 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 6:09 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 6:09 PM | Mauro David J (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2024 6:09 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2024 4:24 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 3:35 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 3:22 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024 3:19 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/08/2024 4:23 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 11:56 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024 7:05 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 7:09 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 7:10 AM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
08/07/2024 12:34 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024 3:50 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024 5:16 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 5:15 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:37 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024 3:17 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 5:52 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4/A | |
07/12/2024 5:54 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 3:51 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 3:51 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 9:38 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
NASDAQ to crash 50%? (Ad) During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out...
Now, he's saying there are four major cracks forming in the US economy...![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9492&Placement=NativeDisplay&Source=NativeDisplay) Click here to learn more >>> |
07/10/2024 3:41 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 11:56 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:30 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 3:25 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/08/2024 3:17 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Recursion Pharmaceuticals (Subject)
| Form SC 13G | |
07/03/2024 3:39 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 3:39 PM | Burrell Terry-Ann (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 3:39 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 3:40 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 4:14 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 6:13 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2024 4:09 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2024 12:04 PM | Recursion Pharmaceuticals (Filer)
| Form 424B5 | |
06/27/2024 7:16 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2024 3:01 PM | Recursion Pharmaceuticals (Filer)
| Form 424B5 | |
06/25/2024 3:21 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 7:02 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 4:46 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2024 4:12 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144/A | |
06/14/2024 3:29 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024 4:36 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2024 3:10 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 8:00 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 9:36 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024 5:11 PM | Li Dean Y (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 5:11 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 5:12 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 5:12 PM | HERSHBERG ROBERT (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 5:12 PM | Burrell Terry-Ann (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 11:30 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 5:31 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:41 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/28/2024 3:22 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 6:11 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 6:11 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 6:12 PM | Mauro David J (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 6:12 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 3:35 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/09/2024 6:46 PM | Recursion Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024 5:24 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 4:41 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2024 9:43 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2024 11:49 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024 3:19 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024 5:41 PM | Marriott Tina (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 4:16 PM | Recursion Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024 4:29 PM | Recursion Pharmaceuticals (Filer)
| Form ARS | |
04/18/2024 4:12 PM | Recursion Pharmaceuticals (Issuer) Secora Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/18/2024 4:12 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:18 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
NASDAQ to crash 50%? (Ad) During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out...
Now, he's saying there are four major cracks forming in the US economy...![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9492&Placement=NativeDisplay&Source=NativeDisplay) Click here to learn more >>> |
04/16/2024 3:55 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144/A | |
04/16/2024 3:15 PM | Recursion Pharmaceuticals (Subject) Secora Michael (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024 7:04 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2024 4:44 PM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Issuer) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 10:13 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024 9:39 AM | Gibson Christopher (Reporting) Recursion Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024 4:42 PM | Borgeson Blake (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 4:42 PM | Burrell Terry-Ann (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 4:43 PM | Dar Zavain (Reporting) Recursion Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |